Jeffrey A M, Liskamp R M
Proc Natl Acad Sci U S A. 1986 Jan;83(2):241-5. doi: 10.1073/pnas.83.2.241.
In the two-stage model of skin carcinogenesis, it is believed that initiators bind to DNA and that tumor promoters such as phorbol 12-tetradecanoate 13-acetate (TPA) bind noncovalently to membrane-associated high-affinity receptors, probably protein kinase C. Two other types of potent tumor-promoting substances, aplysiatoxin and teleocidin, appear to act also by binding to and activating protein kinase C, even though their chemical structures are quite different. Therefore, we have undertaken computer modeling of the special relationship of various functional groups in these three chemical classes of tumor promoters in an attempt to explain how these diverse structures bind to the same receptor molecule. We propose a stereochemical model in which the oxygens in TPA at C-3, C-4, C-9, and C-20 (O-3, O-4, O-9, and O-20) correspond to the O-11, N-13, N-1, and O-24 positions in teleocidin and the O-27, O-3, O-11, and O-30 oxygens in aplysiatoxin, respectively. In this model all distances with respect to overlap of the corresponding atoms are less than 1 A. In addition, all three types of molecules have their hydrophobic moieties oriented in a similar position. This model is further discussed with respect to other compounds showing various degrees of activity as tumor promoters, including mezerein, ingenol, and 4 alpha-TPA. The model explains how chemically diverse structures can have similar biological activity as tumor promoters and provides a basis for designing both agonists and antagonists of tumor promoters.
在皮肤癌发生的两阶段模型中,人们认为引发剂与DNA结合,而肿瘤促进剂如佛波酯12 - 十四烷酸13 - 乙酸酯(TPA)与膜相关的高亲和力受体非共价结合,可能是蛋白激酶C。另外两种强效肿瘤促进物质,海兔毒素和杀鱼菌素,似乎也通过与蛋白激酶C结合并激活它来发挥作用,尽管它们的化学结构有很大不同。因此,我们对这三类肿瘤促进剂中各种官能团的特殊关系进行了计算机建模,试图解释这些不同的结构如何与同一受体分子结合。我们提出了一个立体化学模型,其中TPA中C - 3、C - 4、C - 9和C - 20处的氧原子(O - 3、O - 4、O - 9和O - 20)分别对应于杀鱼菌素中的O - 11、N - 13、N - 1和O - 24位置以及海兔毒素中的O - 27、O - 3、O - 11和O - 30氧原子。在这个模型中,所有对应原子重叠的距离都小于1埃。此外,这三种类型的分子都有其疏水部分位于相似的位置。针对其他显示出不同程度肿瘤促进活性的化合物,包括mezerein、ingenol和4α - TPA,对该模型进行了进一步讨论。该模型解释了化学结构不同的物质如何具有作为肿瘤促进剂的相似生物活性,并为设计肿瘤促进剂的激动剂和拮抗剂提供了基础。